The World Health Organization has updated its essential medicines list to include key diabetes treatments, improving access to innovative care. Advancements also feature AI-paired devices and smarter insulin systems for better management. These tools aim to enhance monitoring and delay onset in at-risk groups.

Recent developments in diabetes care include smarter insulin delivery systems and an AI-paired artificial pancreas, highlighted on September 11, 2025.

In a small cell therapy trial, 10 out of 12 participants with type 1 diabetes no longer required supplemental insulin one year after treatment. This represents a promising advancement in diabetes management.